Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: Cancer-derived small extracellular vesicles: emerging biomarkers and therapies for pancreatic ductal adenocarcinoma diagnosis/prognosis and treatment

Fig. 2

Molecular analysis of components in/on sEVs for PDAC diagnosis/prognosis. PDAC-derived sEVs circulating in blood can be enriched by techniques such as ultracentrifugation. Molecular components including RNAs, DNAs, proteins, lipids and glycans can be analyzed to generate the unique molecular signature for PDAC diagnosis/prognosis

Back to article page